The Food and Drug Administration last week authorized for emergency use a test kit to help identify individuals with an adaptive immune response to SARS-CoV-2, indicating a recent or prior infection. Only laboratories certified under the Clinical Laboratory Improvement Amendments that meet requirements to perform high or moderate complexity tests may use the Diazyme SARS-CoV-2 Neutralizing Antibody CLIA Kit. Negative results do not preclude acute COVID-19 infection, the agency said.

Related News Articles

Headline
As the Department of Health and Human Services prepares to end the COVID-19 public health emergency on May 11, AHA today recommended the agency take immediate…
Headline
The Food and Drug Administration last week removed the requirement for a positive COVID-19 test result to prescribe Paxlovid to certain adult and…
Headline
The Centers for Medicare & Medicaid Services this week released updated fact sheets for hospitals and other types of Medicare and Medicaid providers…
Headline
Health care providers who received Provider Relief Fund and/or American Rescue Plan Rural payments exceeding $10,000 total between July 1 and Dec. 31, 2021,…
Headline
The House last night voted 220-210 to pass legislation (H.R.382) that would immediately terminate the COVID-19 public health emergency, and 227-203 to pass…
Headline
As the Congressional Telehealth Caucus considers updates to legislation that would permanently remove all geographic restrictions on Medicare telehealth…